What kind of evidence is included on the SS-31 human studies page?

Only PubMed-verified publications and explicitly labeled editorial-review gaps are included.

Does this page provide medical advice or human-use guidance?

No. Atlas provides an educational publication map and does not provide sourcing, human-use instructions, or individual medical guidance.

Authority cluster

SS-31: Human studies

Verified human publications, study designs, findings, and explicit limitations.

Publication records

2 verified studies

Search all studies →

Grade AHuman randomized trial2023PubMed metadata verified

Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.

Verified PubMed record for SS-31: Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.

Journal: Neurology
Evidence context: High-level synthesis or controlled evidence

Review study record →

Grade AHuman randomized trial2024PubMed metadata verified

Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial.

Verified PubMed record for SS-31: Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial.

Journal: Orphanet journal of rare diseases
Evidence context: High-level synthesis or controlled evidence

Review study record →

SS-31: Human studies

2 verified studies

Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.

Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial.

Related topic hubs

Pay with Venmo, Cash App & more